Video Transcription
Sir, we've received the quarterly report. What course of action do you suggest?
Our investors have asked for more variety in our products.
Should we cut funding to the research department to increase development?
Our condoms are of the highest quality, but we need to reproduce this in subsequent versions.
Shall we begin testing immediately?
,webp/026/215/196/v2/2560x1440.207.webp)
,webp/024/836/964/v2/2560x1440.204.webp)
,webp/018/431/483/v2/2560x1440.214.webp)
,webp/026/101/346/v2/2560x1440.227.webp)
,webp/008/363/324/v2/2560x1440.210.webp)
,webp/001/950/604/v2/2560x1440.211.webp)
,webp/002/624/050/v2/2560x1440.227.webp)
,webp/006/754/204/1280x720.10.jpg)
,webp/018/595/235/v2/2560x1440.245.webp)
,webp/026/436/155/v2/2560x1440.234.webp)
,webp/026/357/213/v2/2560x1440.212.webp)
